New medicines could be hit by credit crunch27th October 2008
Experts have said the credit crunch could affect the development of new types of medicine and treatment.
Professor David Wield, of the government-backed Economic and Social Research Council, said: "Venture capital is very important to biotech firms. It is often the main source of funding in the early stages of development and, without this, biotech firms will struggle to get their projects off the ground."
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: New medicines could be hit by credit crunch
Author: Jess Laurence
Article Id: 8917
Date Added: 27th Oct 2008